Wells Fargo analyst Roger Read upgrades NOV (NYSE:NOV) from Underweight to Equal-Weight and raises the price target from $16 to $25.
Price Over Earnings Overview: DuPont de Nemours
In the current session, the stock is trading at $70.94, after a 0.88% spike. Over the past month,…